Exome sequencing of patients with Crohn’s disease (CD) of Ashkenazi Jewish descent and genotyping of large case–control cohorts has identified new CD risk and protective variants of LRRK2, the most common genetic determinant of Parkinson disease. These findings provide new insights into the pathophysiology of these two seemingly unrelated disorders.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Derkinderen, P. et al. Parkinson disease: the enteric nervous system spills its guts. Neurology 77, 1761–1767 (2011).
Bialecka, M. et al. CARD15 variants in patients with sporadic Parkinson’s disease. Neurosci. Res. 57, 473–476 (2007).
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
Hui, K. Y. et al. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease. Sci Transl Med. 10, eaai7795 (2018).
Moehle, M. S. et al. LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602–1611 (2012).
Liu, Z. et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063–1070 (2011).
Lin, J. C. et al. Association between Parkinson’s disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort Study. Inflamm. Bowel Dis. 22, 1049–1055 (2016).
Fujioka, S. et al. Occurrence of crohn’s disease with Parkinson’s disease. Parkinsonism Relat. Disord. 37, 116–117 (2017).
Acknowledgements
The authors acknowledge the part funding of their research on Parkinson’s disease by Comité d’entente et de coordination des associations de Parkinsoniens (CECAP), France Parkinson et Parkinsoniens de Vendée.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Derkinderen, P., Neunlist, M. Crohn’s and Parkinson disease: is LRRK2 lurking around the corner?. Nat Rev Gastroenterol Hepatol 15, 330–331 (2018). https://doi.org/10.1038/s41575-018-0006-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-018-0006-9
This article is cited by
-
Die Rolle des Darmmikrobioms beim idiopathischen Parkinson-Syndrom
Der Nervenarzt (2020)
-
Enteric alpha-synuclein expression is increased in Crohn’s disease
Acta Neuropathologica (2019)